Showing results (631-640 of 790) with videos related to

Sort By:
Pageof 79
Molecular Cancer Therapeutics|April 2, 2013
Gossypin as a novel selective dual inhibitor of V-RAF murine sarcoma viral oncogene homolog B1 and cyclin-dependent kinase 4 for melanomaShylesh Bhaskaran, Kalarikkal V Dileep, Sathyaseelan S Deepa, et al.
Journal of Clinical Medicine|June 10, 2022
Novel Therapies for the Treatment of Neuropathic Pain: Potential and PitfallsPottathil Shinu, Mohamed A Morsy, Anroop B Nair, et al.
FEMS Immunology and Medical Microbiology|May 1, 1994
Production and cross-reactivity patterns of a panel of high affinity monoclonal antibodies to Vibrio cholerae O139 BengalS Garg, T Ramamurthy, A K Mukhopadhyay, et al.
Biomed Research International|December 10, 2019
Mucoadhesive Particles: A Novel, Prolonged-Release Nanocarrier of Sitagliptin for the Treatment of DiabeticsNagaraja SreeHarsha, Chandramouli Ramnarayanan, Bandar E Al-Dhubiab, et al.
Journal of Clinical Pathology|February 16, 2010
Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic studyKhushnooma Y Italia, Farah F Jijina, Rashid Merchant, et al.
Gels (Basel, Switzerland)|June 23, 2022
Intranasal Delivery of Darunavir-Loaded Mucoadhesive In Situ Gel: Experimental Design, In Vitro Evaluation, and Pharmacokinetic StudiesAnroop B Nair, Sunita Chaudhary, Hiral Shah, et al.
Methods in Enzymology|May 10, 2012
Nanoparticle-mediated targeted delivery of antiretrovirals to the brainSupriya D Mahajan, Wing-Cheung Law, Ravikumar Aalinkeel, et al.
FEMS Microbiology Letters|March 14, 2000
Genomic diversity among Vibrio cholerae O139 strains isolated in Bangladesh and India between 1992 and 1998S M Faruque, M N Saha, Asadulghani, et al.
Journal of Clinical Microbiology|June 12, 1999
Clonal diversity among recently emerged strains of Vibrio parahaemolyticus O3:K6 associated with pandemic spreadP K Bag, S Nandi, R K Bhadra, et al.
Pageof 79